1001600-56-1

Basic information

• Product Name: BV6
• Synonyms: BV6;N,N'-(hexane-1,6-diyl)bis(1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-L-prolyl-beta-phenyl-L-phenylalaninamide):trifluoroacetic acid(1:x);4,4'-(1,6-Hexanediyl)bis[N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-L-prolyl-beta-phenyl-L-phenylalaninamide
• CAS NO: 1001600-56-1
• Molecular Formula: C₇₀H₉₆N₁₀O₈
• Molecular Weight: 1205.57344
• Product Categories: Inhibitors
• Mol File: 1001600-56-1.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 1376.7±65.0 °C(Predicted)
• Appearance: /
• Density: 1.177±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• Solubility: ≥60.28 mg/mL in DMSO; insoluble in H2O; ≥12.6 mg/mL in EtOH with ultrasonic
• PKA: 12.89±0.20(Predicted)
• CAS DataBase Reference: BV6(CAS DataBase Reference)
• NIST Chemistry Reference: BV6(1001600-56-1)
• EPA Substance Registry System: BV6(1001600-56-1)

Safety Data

• Hazardous Substances Data: 1001600-56-1(Hazardous Substances Data)

Usage

Description

N,N'-(hexane-1,6-diyl)bis(1-(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl-L-prolyl-beta-phenyl-L-phenylalaninamide) is a complex organic compound with a unique molecular structure. It is characterized by its hexane-1,6-diyl bis-structure and the presence of various functional groups, including cyclohexyl, acetyl, prolyl, and phenylalaninamide moieties. N,N'-(hexane-1,6-diyl)bis(1-(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl-L-prolyl-beta-phenyl-L-phenylalaninamide) is likely to have specific interactions with biological systems due to its intricate structure and functional groups.

Uses

1. Used in Pharmaceutical Industry:
N,N'-(hexane-1,6-diyl)bis(1-(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl-L-prolyl-beta-phenyl-L-phenylalaninamide) is used as a potential therapeutic agent for various medical applications. Its complex structure and functional groups may allow it to interact with specific biological targets, making it a candidate for the development of new drugs.
2. Used in Research and Development:
N,N'-(hexane-1,6-diyl)bis(1-(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl-L-prolyl-beta-phenyl-L-phenylalaninamide) can be utilized in research settings to study its interactions with biological systems, such as proteins, enzymes, and receptors. Understanding these interactions can provide valuable insights into the compound's potential applications and mechanisms of action.
3. Used in Drug Design and Optimization:
The unique structure of N,N'-(hexane-1,6-diyl)bis(1-(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl-L-prolyl-beta-phenyl-L-phenylalaninamide) makes it a valuable starting point for the design and optimization of new drugs. Researchers can use this compound as a template to develop more potent and selective therapeutic agents.
4. Used in Chemical Synthesis:
The compound can also be used as a building block or intermediate in the synthesis of other complex organic molecules. Its unique structure and functional groups may be exploited to create novel chemical entities with specific properties and applications.

Relevant articles and documents

INHIBITORS OF IAP

The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds having the general formula U1 - M - U2 wherein M is a linking group covalently joining R2, R3, R4 or R5 of U1 to an R2, R3, R4 or R5 group of U2; U1 and U2 have the general formula (I) and G, X1, X2, R2, R3, R3', R4, R4' and R5, are as described herein.